Published in Brachytherapy on October 22, 2009
Is there an optimal management for localized prostate cancer? Clin Interv Aging (2010) 0.91
Single-fraction high-dose-rate brachytherapy using real-time transrectal ultrasound based planning in combination with external beam radiotherapy for prostate cancer: dosimetrics and early clinical results. J Contemp Brachytherapy (2016) 0.75
Cross-linked hyaluronan gel reduces the acute rectal toxicity of radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys (2010) 0.97
A prospective study of intrafraction prostate motion in the prone vs. supine position. Int J Radiat Oncol Biol Phys (2009) 0.97
A Contura catheter offers dosimetric advantages over a MammoSite catheter that increase the applicability of accelerated partial breast irradiation. Brachytherapy (2009) 0.84
Results with accelerated partial breast irradiation in terms of estrogen receptor, progesterone receptor, and human growth factor receptor 2 status. Int J Radiat Oncol Biol Phys (2010) 0.83
Cross-linked hyaluronan gel improves the quality of life of prostate cancer patients undergoing radiotherapy. Brachytherapy (2010) 0.83
Use of Yttrium-90 TheraSphere for the treatment of unresectable hepatocellular carcinoma. Am Surg (2004) 0.81
Preliminary results with accelerated partial breast irradiation in high-risk breast cancer patients. Brachytherapy (2009) 0.79
Preliminary Results in 173 Breast Cancer Patients Treated with Post-Lumpectomy MammoSite Single-Lumen Brachytherapy or Multi-Catheter Brachytherapy. Breast J (2010) 0.76
Four-year outcomes of hypofractionated high-dose-rate prostate brachytherapy and external beam radiotherapy. Brachytherapy (2013) 0.75